Correlation Between Tekla Healthcare and Mfs Research

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tekla Healthcare and Mfs Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tekla Healthcare and Mfs Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tekla Healthcare Investors and Mfs Research Fund, you can compare the effects of market volatilities on Tekla Healthcare and Mfs Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tekla Healthcare with a short position of Mfs Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tekla Healthcare and Mfs Research.

Diversification Opportunities for Tekla Healthcare and Mfs Research

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Tekla and Mfs is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Tekla Healthcare Investors and Mfs Research Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mfs Research and Tekla Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tekla Healthcare Investors are associated (or correlated) with Mfs Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mfs Research has no effect on the direction of Tekla Healthcare i.e., Tekla Healthcare and Mfs Research go up and down completely randomly.

Pair Corralation between Tekla Healthcare and Mfs Research

Assuming the 90 days horizon Tekla Healthcare Investors is expected to under-perform the Mfs Research. But the mutual fund apears to be less risky and, when comparing its historical volatility, Tekla Healthcare Investors is 1.37 times less risky than Mfs Research. The mutual fund trades about -0.21 of its potential returns per unit of risk. The Mfs Research Fund is currently generating about -0.15 of returns per unit of risk over similar time horizon. If you would invest  6,435  in Mfs Research Fund on October 9, 2024 and sell it today you would lose (589.00) from holding Mfs Research Fund or give up 9.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Tekla Healthcare Investors  vs.  Mfs Research Fund

 Performance 
       Timeline  
Tekla Healthcare Inv 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tekla Healthcare Investors has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's technical indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Mfs Research 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mfs Research Fund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward-looking signals, Mfs Research is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Tekla Healthcare and Mfs Research Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tekla Healthcare and Mfs Research

The main advantage of trading using opposite Tekla Healthcare and Mfs Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tekla Healthcare position performs unexpectedly, Mfs Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mfs Research will offset losses from the drop in Mfs Research's long position.
The idea behind Tekla Healthcare Investors and Mfs Research Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies